Adaptation and validation of a German version of the Multimorbidity Treatment Burden Questionnaire.
Adherence
Comorbidity
Patient-centred care
Patient-reported outcome
Primary care
Quality of life
Journal
Health and quality of life outcomes
ISSN: 1477-7525
Titre abrégé: Health Qual Life Outcomes
Pays: England
ID NLM: 101153626
Informations de publication
Date de publication:
03 Jun 2022
03 Jun 2022
Historique:
received:
05
10
2021
accepted:
17
05
2022
entrez:
6
6
2022
pubmed:
7
6
2022
medline:
9
6
2022
Statut:
epublish
Résumé
Patients with multiple long-term conditions often face a variety of challenges arising from the requirements of their health care. Knowledge of perceived treatment burden is crucial for optimizing treatment. In this study, we aimed to create a German version of the Multimorbidity Treatment Burden Questionnaire (MTBQ) and to evaluate its validity. The steps to translate the MTBQ included forward/back translation, cognitive interviews (n = 6) and a pilot test (n = 7). Psychometric properties of the scale were assessed in a cross-sectional survey with primary care patients aged 65 and older with at least 3 long-term conditions (n = 344). We examined the distribution of responses, dimensionality, internal reliability and construct validity. Cognitive interviewing and piloting led to minor modifications and showed overall good face validity and acceptability. As expected, we observed a positively skewed response distribution for all items. Reliability was acceptable with McDonald's omega = 0.71. Factor analysis suggested one common factor while model fit indices were inconclusive. Predefined hypotheses regarding the construct validity were supported by negative associations between treatment burden and health-related quality of life, self-rated health, social support, patient activation and medication adherence, and positive associations between treatment burden and number of comorbidities. Treatment burden was found to be higher in female participants (Mdn The German MTBQ exhibited good psychometric properties and can be used to assess the perceived treatment burden of patients with multimorbidity.
Sections du résumé
BACKGROUND
BACKGROUND
Patients with multiple long-term conditions often face a variety of challenges arising from the requirements of their health care. Knowledge of perceived treatment burden is crucial for optimizing treatment. In this study, we aimed to create a German version of the Multimorbidity Treatment Burden Questionnaire (MTBQ) and to evaluate its validity.
METHODS
METHODS
The steps to translate the MTBQ included forward/back translation, cognitive interviews (n = 6) and a pilot test (n = 7). Psychometric properties of the scale were assessed in a cross-sectional survey with primary care patients aged 65 and older with at least 3 long-term conditions (n = 344). We examined the distribution of responses, dimensionality, internal reliability and construct validity.
RESULTS
RESULTS
Cognitive interviewing and piloting led to minor modifications and showed overall good face validity and acceptability. As expected, we observed a positively skewed response distribution for all items. Reliability was acceptable with McDonald's omega = 0.71. Factor analysis suggested one common factor while model fit indices were inconclusive. Predefined hypotheses regarding the construct validity were supported by negative associations between treatment burden and health-related quality of life, self-rated health, social support, patient activation and medication adherence, and positive associations between treatment burden and number of comorbidities. Treatment burden was found to be higher in female participants (Mdn
CONCLUSIONS
CONCLUSIONS
The German MTBQ exhibited good psychometric properties and can be used to assess the perceived treatment burden of patients with multimorbidity.
Identifiants
pubmed: 35658972
doi: 10.1186/s12955-022-01993-z
pii: 10.1186/s12955-022-01993-z
pmc: PMC9166496
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
90Subventions
Organisme : G-BA Innovationsfonds
ID : 01VSF16058
Informations de copyright
© 2022. The Author(s).
Références
Behav Res Methods. 2007 Nov;39(4):979-84
pubmed: 18183915
Gerontologist. 2022 Jan 28;:
pubmed: 35090014
Med Care. 2014 Mar;52 Suppl 3:S118-25
pubmed: 24561750
BMC Public Health. 2015 Apr 23;15:415
pubmed: 25903064
J Eval Clin Pract. 2010 Jun;16(3):574-9
pubmed: 20210821
BMJ Open. 2018 Apr 12;8(4):e019413
pubmed: 29654011
Mayo Clin Proc. 2020 Mar;95(3):504-512
pubmed: 31619365
BMC Fam Pract. 2018 Jan 9;19(1):9
pubmed: 29316892
PLoS One. 2021 Jan 12;16(1):e0245112
pubmed: 33434200
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
BMC Fam Pract. 2019 Jun 28;20(1):88
pubmed: 31253097
Lancet. 2018 Jul 7;392(10141):41-50
pubmed: 29961638
Patient Educ Couns. 2019 Oct;102(10):1932-1938
pubmed: 31151781
Patient Relat Outcome Meas. 2012;3:39-49
pubmed: 23185121
J Gen Intern Med. 2017 Oct;32(10):1141-1145
pubmed: 28699060
Patient Prefer Adherence. 2014 Mar 19;8:339-51
pubmed: 24672228
PLoS One. 2017 Jun 23;12(6):e0179916
pubmed: 28644877
BMJ Open. 2022 Jan 3;12(1):e055276
pubmed: 34980626
Qual Life Res. 2017 Feb;26(2):489-503
pubmed: 27566732
BMC Fam Pract. 2020 Oct 28;21(1):221
pubmed: 33115421
Age Ageing. 2018 May 01;47(3):374-380
pubmed: 29370339
JAMA. 2005 Aug 10;294(6):716-24
pubmed: 16091574
J R Coll Physicians Edinb. 2015;45(2):114-7
pubmed: 26181525
BMJ Open. 2021 Jun 15;11(6):e047025
pubmed: 34130962
BMC Med. 2014 Jul 02;12:109
pubmed: 24989988
Health Qual Life Outcomes. 2020 Jun 22;18(1):194
pubmed: 32571343
J Am Board Fam Med. 2011 Jul-Aug;24(4):380-90
pubmed: 21737762
PLoS One. 2013 Sep 30;8(9):e74786
pubmed: 24098669
PLoS One. 2013 Dec 20;8(12):e81852
pubmed: 24376504
BMC Med. 2012 Jul 04;10:68
pubmed: 22762722
J Clin Epidemiol. 2012 Oct;65(10):1041-51
pubmed: 22910536
Rehabilitation (Stuttg). 2015 Feb;54(1):53-9
pubmed: 25675322